Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Colorectal Cancer Diagnostic Tests Overview
  • Products under Development
    • Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
      • Table Figure 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
      • Table Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
    • Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Figure 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
    • Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Figure 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
    • Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
    • Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Figure 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
  • Colorectal Cancer Diagnostic Tests - Pipeline Products under Development by Companies
    • Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
      • Table Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
    • Colorectal Cancer Diagnostic Tests – Companies Pipeline Products by Stage of Development
      • Table Colorectal Cancer Diagnostic Tests – Companies Pipeline Products by Stage of Development
  • Colorectal Cancer Diagnostic Tests Companies and Product Overview
    • Abcodia Ltd Company Overview
      • Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status(Abcodia Ltd)
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description(Abcodia Ltd)
    • Almac Diagnostic Services Ltd Company Overview
      • Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests – Product Description
    • Ambergen Inc Company Overview
      • Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Veracode - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Veracode - Colorectal Cancer Diagnostic Tests - Product Description
    • ANGLE plc Company Overview
      • ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Anixa Diagnostics Corporation Company Overview
      • Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cchek - Colon Cancer Confirmatory Test - Product Status
        • Table Cchek - Colon Cancer Confirmatory Test - Product Description
        • Table Cchek - Colon Cancer Recurrence Test - Product Status
        • Table Cchek - Colon Cancer Recurrence Test - Product Description
        • Table Cchek - Colon Cancer Screening Test - Product Status
        • Table Cchek - Colon Cancer Screening Test - Product Description
        • Table Cchek - Colon Cancer Treatment Monitoring Test - Product Status
        • Table Cchek - Colon Cancer Treatment Monitoring Test - Product Description
        • Table Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview
        • Table Cchek - Colon Cancer Screening Test - Cchek Cancer Patient Efficacy Study
        • Table Cchek - Colon Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors
    • Applied Proteomics Inc Company Overview
      • Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SimpliPro Colon-A - Product Status
        • Table SimpliPro Colon-A - Product Description
    • Arizona State University Company Overview
      • Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Arrayit Corporation Company Overview
      • Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Finger Stick Test - Colon Cancer - Product Status
        • Table Finger Stick Test - Colon Cancer - Product Description
    • ArtemixRx Company Overview
      • ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
        • Table ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
        • Table ArtemixRx Prognostic Test - Colon Cancer - Product Status
        • Table ArtemixRx Prognostic Test - Colon Cancer - Product Description
    • Avant Diagnostics Inc Company Overview
      • Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • Bio Mark Ltd Company Overview
      • Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Adenoma - Product Status
        • Table Diagnostic Test - Colorectal Adenoma - Product Description
    • Biocartis Group NV Company Overview
      • Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Idylla MSI CDx - Product Status
        • Table Idylla MSI CDx - Product Description
        • Table Idylla MSI Test - Product Status
        • Table Idylla MSI Test - Product Description
    • Biodesix Inc Company Overview
      • Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VeriStrat - Colorectal Cancer Diagnostic Tests - Product Status
        • Table VeriStrat - Colorectal Cancer Diagnostic Tests - Product Description
    • BioMarCare Technologies Ltd Company Overview
      • BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table mCRC-Strat - Product Status
        • Table mCRC-Strat - Product Description
    • BioMark Diagnostics Inc Company Overview
      • BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolomics-based Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Metabolomics-based Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • BioMarker Strategies LLC Company Overview
      • BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ex Vivo Biomarker Test - Colon Cancer - Product Status
        • Table Ex Vivo Biomarker Test - Colon Cancer - Product Description
    • Biomoda Inc Company Overview
      • Biomoda Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomoda Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CyPath Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table CyPath Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • Bioprognos SL Company Overview
      • Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table MBDAA Colorectal Cancer Test - Product Status
        • Table MBDAA Colorectal Cancer Test - Product Description
    • BioSystems International Company Overview
      • BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colon Cancer - Product Status(BioSystems International)
        • Table Diagnostic Test - Colon Cancer - Product Description(BioSystems International)
    • Biotron Ltd Company Overview
      • Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table C-Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table C-Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Calviri Inc Company Overview
      • Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Test - Microsatellite Instability Status - Product Status
        • Table Blood Test - Microsatellite Instability Status - Product Description
    • Castle Biosciences Inc Company Overview
      • Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DecisionDx - Rectal Cancer - Product Status
        • Table DecisionDx - Rectal Cancer - Product Description
    • Catholic University of Leuven Company Overview
      • Catholic University of Leuven Pipeline Products & Ongoing Clinical Trials Overview
        • Table Catholic University of Leuven Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status(Catholic University of Leuven)
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description(Catholic University of Leuven)
    • Celcuity Inc Company Overview
      • Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CELx Test - Colon Cancer - Product Status
        • Table CELx Test - Colon Cancer - Product Description
    • CellMax Life Inc Company Overview
      • CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CellMax Monitor - Colorectal Cancer Diagnostic Tests - Product Status
        • Table CellMax Monitor - Colorectal Cancer Diagnostic Tests - Product Description
    • Cellmid Ltd Company Overview
      • Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MK-ELISA Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table MK-ELISA Assay - Colorectal Cancer Diagnostic Tests - Product Description
        • Table MK-ELISA Assay - Metastatic Colorectal Cancer Diagnostic Tests - Product Status
        • Table MK-ELISA Assay - Metastatic Colorectal Cancer Diagnostic Tests - Product Description
    • Ceres Nanosciences Inc Company Overview
      • Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotrap Colon Cancer Biomarker Test - Product Status
        • Table Nanotrap Colon Cancer Biomarker Test - Product Description
    • Cernostics Inc Company Overview
      • Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TissueCypher Colon Cancer Test - Product Status
        • Table TissueCypher Colon Cancer Test - Product Description
    • ChemImage Corp Company Overview
      • ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Raman Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Raman Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • China Sky One Medical Inc Company Overview
      • China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Kit - Rectum Cancer - Product Status
        • Table Diagnostic Kit - Rectum Cancer - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table IGFBP-3 Diagnostic Test - Product Status
        • Table IGFBP-3 Diagnostic Test - Product Description
    • CS-Keys, Inc. (Inactive) Company Overview
      • CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table caPCNA Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table caPCNA Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Di.V.A.L Toscana srl Company Overview
      • Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoMabKv - Colorectal Cancer Diagnostic Tests - Product Status
        • Table NanoMabKv - Colorectal Cancer Diagnostic Tests - Product Description
    • DiagnoCure Inc. (Inactive) Company Overview
      • DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colorectal/GCC Monitoring Test - Product Status
        • Table Colorectal/GCC Monitoring Test - Product Description
        • Table Colorectal/Shc Prognostic Test - Product Status
        • Table Colorectal/Shc Prognostic Test - Product Description
    • Diazyme Laboratories Inc Company Overview
      • Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TRAIL-R2 Assay - Product Status
        • Table TRAIL-R2 Assay - Product Description
    • DNAlytics SA Company Overview
      • DNAlytics SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table DNAlytics SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ColonoKit - Product Status
        • Table ColonoKit - Product Description
        • Table DNAlytics SA - Ongoing Clinical Trials Overview
        • Table ColonoKit - ColonoKit Clinical Evaluation in Colorectal Cancer Subjects
    • Duke University Company Overview
      • Duke University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Duke University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Colon Cancer - Product Status(Duke University)
        • Table Biomarker Test - Colon Cancer - Product Description(Duke University)
    • EDP Biotech Corporation Company Overview
      • EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table ColoPlex - Product Status
        • Table ColoPlex - Product Description
    • EntreChem SL Company Overview
      • EntreChem SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table EntreChem SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bacterial Biomarker Test - Colon Cancer - Product Status
        • Table Bacterial Biomarker Test - Colon Cancer - Product Description
    • Epigenomics AG Company Overview
      • Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epi proColon 1.0 - Product Status
        • Table Epi proColon 1.0 - Product Description
    • Eurobio Scientific SA Company Overview
      • Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table EHT Dx 12 - Product Status
        • Table EHT Dx 12 - Product Description
    • Eventus Diagnostics Inc (Inactive) Company Overview
      • Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Octava Test - Colon Cancer - Product Status
        • Table Octava Test - Colon Cancer - Product Description
    • Exact Sciences Corp Company Overview
      • Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table PreGen-Plus - Product Status
        • Table PreGen-Plus - Product Description
    • Exiqon AS Company Overview
      • Exiqon AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exiqon AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colon Cancer Test - Stage III And IV Patient - Product Status
        • Table Colon Cancer Test - Stage III And IV Patient - Product Description
    • Exosomics Siena SpA Company Overview
      • Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ExoTEST Colorectal - Product Status
        • Table ExoTEST Colorectal - Product Description
    • Fina Biotech SL Company Overview
      • Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dx Bioenergetic Signature - Colon Cancer - Product Status
        • Table Dx Bioenergetic Signature - Colon Cancer - Product Description
    • Fox Chase Cancer Center Company Overview
      • Fox Chase Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fox Chase Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status(Fox Chase Cancer Center)
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description(Fox Chase Cancer Center)
        • Table Prognostic Marker - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Prognostic Marker - Colorectal Cancer Diagnostic Tests - Product Description
    • GenExosome Technologies Inc Company Overview
      • GenExosome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GenExosome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EXOSOME Biomarker Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table EXOSOME Biomarker Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • GenomicTree Inc Company Overview
      • GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EarlyTect Colon Cancer - Product Status
        • Table EarlyTect Colon Cancer - Product Description
        • Table EarlyTect Colorectal Cancer Diagnostic Tests - Recurrence - Product Status
        • Table EarlyTect Colorectal Cancer Diagnostic Tests - Recurrence - Product Description
    • German Cancer Research Center Company Overview
      • German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Autoantibody Panel - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Autoantibody Panel - Colorectal Cancer Diagnostic Tests - Product Description
        • Table Biomarker Panel - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Biomarker Panel - Colorectal Cancer Diagnostic Tests - Product Description
    • Ghent University Company Overview
      • Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description
    • GlycoZym Company Overview
      • GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Colon Cancer - Product Status(GlycoZym)
        • Table Diagnostic Assay - Colon Cancer - Product Description(GlycoZym)
    • GoodGut SL Company Overview
      • GoodGut SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table GoodGut SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table RAID-CRC - Product Status
        • Table RAID-CRC - Product Description
    • Health Discovery Corp Company Overview
      • Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colon Cancer - Product Status(Health Discovery Corp)
        • Table Diagnostic Test - Colon Cancer - Product Description(Health Discovery Corp)
    • Hitachi Chemical Diagnostics Inc Company Overview
      • Hitachi Chemical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hitachi Chemical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Urine Based Diagnostic Test - Colon Cancer - Product Status(Hitachi Chemical Diagnostics Inc)
        • Table Urine Based Diagnostic Test - Colon Cancer - Product Description(Hitachi Chemical Diagnostics Inc)
    • Human Metabolome Technologies Inc Company Overview
      • Human Metabolome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Human Metabolome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Based Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Biomarker Based Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • Ikonisys Inc Company Overview
      • Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table oncoFISH colorectal - Product Status
        • Table oncoFISH colorectal - Product Description
    • Institute of Molecular and Translational Medicine Company Overview
      • Institute of Molecular and Translational Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Institute of Molecular and Translational Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Biomarker - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Biomarker - Colorectal Cancer Diagnostic Tests - Product Description
    • InterGenetics Inc Company Overview
      • InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoVue Colon - Product Status
        • Table OncoVue Colon - Product Description
    • IV Diagnostics Inc Company Overview
      • IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Colon Cancer - Product Status(IV Diagnostics Inc)
        • Table Diagnostic Assay - Colon Cancer - Product Description(IV Diagnostics Inc)
    • Johns Hopkins University Company Overview
      • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table 5hmC Based Diagnostic Tool - Cancer - Product Status
        • Table 5hmC Based Diagnostic Tool - Cancer - Product Description
        • Table mRNA Biomarker - Colon Cancer - Product Status
        • Table mRNA Biomarker - Colon Cancer - Product Description
        • Table Prognosis Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Prognosis Test - Colorectal Cancer Diagnostic Tests - Product Description
    • King Abdullah University of Science and Technology Company Overview
      • King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Kyo Diagnostics KK Company Overview
      • Kyo Diagnostics KK Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kyo Diagnostics KK Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status(Kyo Diagnostics KK)
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description(Kyo Diagnostics KK)
    • Lab21 Ltd Company Overview
      • Lab21 Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lab21 Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Onconostica - Product Status
        • Table Onconostica - Product Description
    • Laboratorios Alpha San Ignacio Pharma S.L. Company Overview
      • Laboratorios Alpha San Ignacio Pharma S.L. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Laboratorios Alpha San Ignacio Pharma S.L. Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoSafe - Product Status
        • Table OncoSafe - Product Description
    • Leitat Technological Center Company Overview
      • Leitat Technological Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Leitat Technological Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table ELISA Kit - S100A4 - Colon Cancer - Product Status
        • Table ELISA Kit - S100A4 - Colon Cancer - Product Description
        • Table ELISA Kit - S100P - Colon Cancer - Product Status
        • Table ELISA Kit - S100P - Colon Cancer - Product Description
    • Lightsphere Diagnostics Company Overview
      • Lightsphere Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lightsphere Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table RACC Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table RACC Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Lineage Cell Therapeutics Inc Company Overview
      • Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PanC-Dx - Colon Cancer - Product Status
        • Table PanC-Dx - Colon Cancer - Product Description
    • MabCure Inc Company Overview
      • MabCure Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MabCure Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status(MabCure Inc)
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description(MabCure Inc)
    • Master Diagnostica Sociedad Limitada Company Overview
      • Master Diagnostica Sociedad Limitada Pipeline Products & Ongoing Clinical Trials Overview
        • Table Master Diagnostica Sociedad Limitada Pipeline Products & Ongoing Clinical Trials Overview
        • Table KRAS / NRAS / BRAF Mutation Flow Chip Test - Colon Cancer - Product Status
        • Table KRAS / NRAS / BRAF Mutation Flow Chip Test - Colon Cancer - Product Description
    • Matrix-Bio Inc Company Overview
      • Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Test - Colon Cancer - Product Status
        • Table Companion Diagnostic Test - Colon Cancer - Product Description
        • Table VeraMarker CCM Test - Product Status
        • Table VeraMarker CCM Test - Product Description
        • Table VeraMarker CCS Test - Product Status
        • Table VeraMarker CCS Test - Product Description
    • Max Delbruck Center for Molecular Medicine Company Overview
      • Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Companion Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • Mayo Clinic Company Overview
      • Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Test - Colon Cancer - Product Status
        • Table Blood Test - Colon Cancer - Product Description
    • MDNA Life Sciences Inc Company Overview
      • MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mitomic Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Mitomic Test - Colorectal Cancer Diagnostic Tests - Product Description
    • MDxHealth SA Company Overview
      • MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table InformMDx - Colon Cancer - Product Status
        • Table InformMDx - Colon Cancer - Product Description
        • Table PredictMDx - Colon Cancer - Product Status
        • Table PredictMDx - Colon Cancer - Product Description
    • Merrimack Pharmaceuticals Inc Company Overview
      • Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MM-151 Companion Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table MM-151 Companion Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • Metabolon Inc Company Overview
      • Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status(Metabolon Inc)
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description(Metabolon Inc)
    • MetaStat Inc Company Overview
      • MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MenaCalc Colorectal - Product Status
        • Table MenaCalc Colorectal - Product Description
    • Milagen Inc Company Overview
      • Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunoassay - Colon Cancer - Product Status
        • Table Immunoassay - Colon Cancer - Product Description
    • Myriad Genetics Inc Company Overview
      • Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colon Cancer - Product Status(Myriad Genetics Inc)
        • Table Diagnostic Test - Colon Cancer - Product Description(Myriad Genetics Inc)
    • Nanocytomics LLC Company Overview
      • Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Minimally Intrusive Fecal Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Minimally Intrusive Fecal Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Norda ASA Company Overview
      • Norda ASA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Norda ASA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genefec III - Product Status
        • Table Genefec III - Product Description
    • Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
      • Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table NBT Diagnostic Test - Colon Cancer - Product Status
        • Table NBT Diagnostic Test - Colon Cancer - Product Description
    • Nuclea Biotechnologies Inc. (Inactive) Company Overview
      • Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colon Cancer Recurrence Diagnostic Test - Product Status
        • Table Colon Cancer Recurrence Diagnostic Test - Product Description
    • Oncimmune (USA) LLC Company Overview
      • Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table EarlyCDT - Colon Cancer - Product Status
        • Table EarlyCDT - Colon Cancer - Product Description
    • Onconome, Inc. (Inactive) Company Overview
      • Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table ColoMark CCSA-4 Serum Assay - Product Status
        • Table ColoMark CCSA-4 Serum Assay - Product Description
    • OncoStem Diagnostics Pvt. Ltd Company Overview
      • OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CanAssist - Colon Cancer - Product Status
        • Table CanAssist - Colon Cancer - Product Description
    • On-Q-ity, Inc. (Inactive) Company Overview
      • On-Q-ity, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table On-Q-ity, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dual-Capture Microfluidic Chip - Colon Cancer - Product Status
        • Table Dual-Capture Microfluidic Chip - Colon Cancer - Product Description
    • Origin Sciences Ltd Company Overview
      • Origin Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Origin Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CRC Test - Product Status
        • Table CRC Test - Product Description
    • Orion Genomics LLC Company Overview
      • Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion CRC Risk Test - Product Status
        • Table Orion CRC Risk Test - Product Description
    • OTraces Inc. Company Overview
      • OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colon Cancer Sera Dx - Product Status
        • Table Colon Cancer Sera Dx - Product Description
    • Oxford Cancer Biomarkers Ltd Company Overview
      • Oxford Cancer Biomarkers Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oxford Cancer Biomarkers Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ColoNav - Product Status
        • Table ColoNav - Product Description
    • Oxford Gene Technology Ltd Company Overview
      • Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status(Oxford Gene Technology Ltd)
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description(Oxford Gene Technology Ltd)
    • PleX Diagnostics Inc (Inactive) Company Overview
      • PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • Precision Biologics Inc Company Overview
      • Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status(Precision Biologics Inc)
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description(Precision Biologics Inc)
    • Prediction Sciences LLC (Inactive) Company Overview
      • Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table GeneRx Colorectal Cancer Profile - Product Status
        • Table GeneRx Colorectal Cancer Profile - Product Description
    • PreMD Inc (Inactive) Company Overview
      • PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colopath/ColorectAlert - Product Status
        • Table Colopath/ColorectAlert - Product Description
    • Prescient Medicine LLC Company Overview
      • Prescient Medicine LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prescient Medicine LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LifeKit Prevent Colorectal Neoplasia Test - Product Status
        • Table LifeKit Prevent Colorectal Neoplasia Test - Product Description
    • Protagen AG Company Overview
      • Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Colon Cancer - Product Status(Protagen AG)
        • Table Diagnostic Assay - Colon Cancer - Product Description(Protagen AG)
    • Protein Alternatives SL Company Overview
      • Protein Alternatives SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protein Alternatives SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table COLODETECT - Product Status
        • Table COLODETECT - Product Description
    • Qiagen NV Company Overview
      • Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Based Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Blood Based Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Quest Diagnostics Inc Company Overview
      • Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description
    • Rabin Medical Center Company Overview
      • Rabin Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rabin Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colon Cancer - Product Status
        • Table Diagnostic Test - Colon Cancer - Product Description
    • Rhythm Biosciences Ltd Company Overview
      • Rhythm Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rhythm Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ColoSTAT - Product Status
        • Table ColoSTAT - Product Description
        • Table Rhythm Biosciences Ltd - Ongoing Clinical Trials Overview
        • Table ColoSTAT - A Prospective, Cross-sectional, Multi-center Study to Evaluate the Clinical Performance of the Colostat in Vitro Diagnostic for the Detection and Evaluation of Biomarkers Associated with the Occurrence of Colorectal Cancer
    • RISE Life Science Corp Company Overview
      • RISE Life Science Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table RISE Life Science Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status(RISE Life Science Corp)
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description(RISE Life Science Corp)
    • Rosetta Genomics Ltd Company Overview
      • Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table miRscreen Test - Colon Cancer - Product Status
        • Table miRscreen Test - Colon Cancer - Product Description
    • Scienion AG Company Overview
      • Scienion AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scienion AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colon Cancer - Product Status(Scienion AG)
        • Table Diagnostic Test - Colon Cancer - Product Description(Scienion AG)
    • Seegene Inc Company Overview
      • Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDx - Colon Cancer - Product Status
        • Table MDx - Colon Cancer - Product Description
    • Shuwen Biotech Co Ltd Company Overview
      • Shuwen Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shuwen Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colorectal Cancer Theranostic Test - Product Status
        • Table Colorectal Cancer Theranostic Test - Product Description
    • Sysmex Corp Company Overview
      • Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Methylated DNA Colon Cancer Diagnostic Test - Product Status
        • Table Methylated DNA Colon Cancer Diagnostic Test - Product Description
    • Tel Aviv University Company Overview
      • Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker-Based Diagnostic Kit - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Biomarker-Based Diagnostic Kit - Colorectal Cancer Diagnostic Tests - Product Description
    • The Chinese University of Hong Kong Company Overview
      • The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colorectal Cancer Screening Tool - Product Status
        • Table Colorectal Cancer Screening Tool - Product Description
    • The Walter and Eliza Hall Institute of Medical Research Company Overview
      • The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood-Based Screening Test - Colon Cancer - Product Status
        • Table Blood-Based Screening Test - Colon Cancer - Product Description
    • TheraDiag SA Company Overview
      • TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Non-invasive Theranostics Test - Metastatic Recurrence - Product Status
        • Table Non-invasive Theranostics Test - Metastatic Recurrence - Product Description
        • Table Non-invasive Theranostics Test - Radiochemotherapy - Product Status
        • Table Non-invasive Theranostics Test - Radiochemotherapy - Product Description
    • Treos Bio Inc Company Overview
      • Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PolyPEPI 1018 CDx - Product Status
        • Table PolyPEPI 1018 CDx - Product Description
        • Table Treos Bio Inc - Ongoing Clinical Trials Overview
        • Table PolyPEPI 1018 CDx - Safety, Tolerability, Immunogenicity and Efficacy of Multiple PolyPEPI1018 Vaccinations as an Add-on Immunotherapy to the Standard-of-care Maintenance Therapy in Subjects with Metastatic Colorectal Cancer
    • Trinity College Dublin Company Overview
      • Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status(Trinity College Dublin)
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description(Trinity College Dublin)
    • Universal Diagnostics SL Company Overview
      • Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Based Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status(Universal Diagnostics SL)
        • Table Blood Based Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description(Universal Diagnostics SL)
    • University of Illinois at Chicago Company Overview
      • University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status(University of Illinois at Chicago)
        • Table Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description(University of Illinois at Chicago)
    • University of Lyon Company Overview
      • University of Lyon Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Lyon Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Prognostic Test - Colon Cancer - Product Status
        • Table Biomarker Prognostic Test - Colon Cancer - Product Description
    • University of Michigan Company Overview
      • University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peptide Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Peptide Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description
    • University of Notre Dame Company Overview
      • University of Notre Dame Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Notre Dame Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Colon Cancer - Product Status(University of Notre Dame)
        • Table Biomarker Test - Colon Cancer - Product Description(University of Notre Dame)
    • University of Pittsburgh Company Overview
      • University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status(University of Pittsburgh)
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description(University of Pittsburgh)
        • Table University of Pittsburgh - Ongoing Clinical Trials Overview
        • Table Biomarker Test - Colorectal Cancer Diagnostic Tests - Use of ctDNA for Monitoring of Stage III Colorectal Cancer
    • University of Texas MD Anderson Cancer Center Company Overview
      • University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Based Assay - Colorectal Neoplasia - Product Status
        • Table Biomarker Based Assay - Colorectal Neoplasia - Product Description
        • Table Biomarker Panel - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Biomarker Panel - Colorectal Cancer Diagnostic Tests - Product Description
    • University of Turku Company Overview
      • University of Turku Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Turku Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lectin-Nanoparticle Biomarker - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Lectin-Nanoparticle Biomarker - Colorectal Cancer Diagnostic Tests - Product Description
    • University of Washington Company Overview
      • University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Colon Cancer - Product Status(University of Washington)
        • Table Diagnostic Test - Colon Cancer - Product Description(University of Washington)
    • University of Wisconsin Madison Company Overview
      • University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Kit - Colon Cancer - Product Status
        • Table Diagnostic Kit - Colon Cancer - Product Description
    • University of Zurich Company Overview
      • University of Zurich Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Zurich Pipeline Products & Ongoing Clinical Trials Overview
        • Table Serum Marker Test - Colorectal Carcinoma - Product Status
        • Table Serum Marker Test - Colorectal Carcinoma - Product Description
    • US Biomarkers Inc Company Overview
      • US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood-Based Biomarker - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Blood-Based Biomarker - Colorectal Cancer Diagnostic Tests - Product Description
    • vall d hebron institut de Recerca Company Overview
      • vall d hebron institut de Recerca Pipeline Products & Ongoing Clinical Trials Overview
        • Table vall d hebron institut de Recerca Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aprataxin Biomarker - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Aprataxin Biomarker - Colorectal Cancer Diagnostic Tests - Product Description
        • Table Companion Diagnostic Assay - Colon Cancer - Product Status
        • Table Companion Diagnostic Assay - Colon Cancer - Product Description
    • Vanderbilt University Company Overview
      • Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - High-Risk Stage II Colorectal Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Test - High-Risk Stage II Colorectal Cancer Diagnostic Tests - Product Description
        • Table VICC Blood-Based Diagnostic Test - Colorectal Cancer Diagnostic Tests – Product Status(Vanderbilt University)
        • Table VICC Blood-Based Diagnostic Test - Colorectal Cancer Diagnostic Tests – Product Description(Vanderbilt University)
    • Vastcon Inc Company Overview
      • Vastcon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vastcon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Screening Test - Colorectal Cancer Diagnostic Tests - Product Status
        • Table Screening Test - Colorectal Cancer Diagnostic Tests - Product Description
    • Viomics Inc. Company Overview
      • Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viomics Diagnostic Assay - Colon Cancer - Product Status
        • Table Viomics Diagnostic Assay - Colon Cancer - Product Description
    • VolitionRX Ltd Company Overview
      • VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nu.Q CRC Screening Test - Product Status
        • Table Nu.Q CRC Screening Test - Product Description
        • Table Nu.Q CRC Symptomatic Test - Product Status
        • Table Nu.Q CRC Symptomatic Test - Product Description
        • Table Nu.Q CRC Triage Test - Product Status
        • Table Nu.Q CRC Triage Test - Product Description
        • Table Nu.Q Frontline Asymptomatic CRC Screening Test - Product Status
        • Table Nu.Q Frontline Asymptomatic CRC Screening Test - Product Description
        • Table VolitionRX Ltd - Ongoing Clinical Trials Overview
        • Table Nu.Q CRC Screening Test - A Large Multi-center US Clinical Study of Nu.Q Assay in the Screening of Colorectal Cancer
        • Table Nu.Q CRC Screening Test - Prospective Clinical Study Nu.Q Assay for the Detection of Colorectal Cancer
        • Table Nu.Q Frontline Asymptomatic CRC Screening Test - Asymptomatic Colorectal Cancer (CRC) Frontline Screening Study
    • XEPTAGEN SpA Company Overview
      • XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table CA19.9 - IgM Kit - Product Status
        • Table CA19.9 - IgM Kit - Product Description
  • Colorectal Cancer Diagnostic Tests - Recent Developments
    • Nov 21, 2019: Development of colorectal cancer detection kit
    • Nov 21, 2019: Pacific Edge announces FY20 results and capital raising
    • Nov 19, 2019: Epigenomics reports financial results for the first nine months 2019
    • Nov 15, 2019: StageZero Life Sciences announces Q3 2019 progress update
    • Nov 14, 2019: Biocartis Q3 2019 business update
    • Nov 14, 2019: BioIQ conducts one millionth colorectal cancer screening
    • Nov 14, 2019: Biocartisb Q3 2019 business update
    • Nov 12, 2019: Lineage Cell Therapeutics reports third quarter 2019 financial results and provides business update
    • Nov 12, 2019: VolitionRx announces third quarter 2019 financial results and business update
    • Nov 12, 2019: Vermillion reports third quarter 2019 financial results
    • Nov 12, 2019: OGT continues move into molecular diagnostics markets
    • Nov 11, 2019: MDxHealth provides Q3-2019 business update
    • Nov 06, 2019: StageZero Life Sciences makes ColonSentry blood test available to consumers through online Telehealth platform
    • Nov 05, 2019: Biocartis NV: Five Idylla studies to be published at `Association for Molecular Pathology' Annual Meeting (US)
    • Nov 04, 2019: Myriad Genetics reports fiscal first-quarter 2020 financial results
    • Oct 31, 2019: CELLMID appoints CEO to Advagen USA to expand distribution
    • Oct 30, 2019: PRA Health Sciences reports third quarter 2019 results and updates full year 2019 guidance
    • Oct 29, 2019: Exact Sciences presents new stool-based Colorectal Cancer screening performance data, initiates prospective screening study
    • Oct 29, 2019: Illumina celebrates grand opening of its solutions center in the University of Maryland BioPark
    • Oct 29, 2019: Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million
    • Oct 29, 2019: NeoGenomics reports 51% revenue growth to $105 million in the third quarter
    • Oct 29, 2019: New grant aims to increase Colorectal Cancer screening, follow-up care in Appalachia
    • Oct 24, 2019: Calviri awarded NCI grant for the development of a new blood test that may predict responders to checkpoint Inhibitor Therapies
    • Oct 24, 2019: Illumina reports financial results for third quarter of fiscal year 2019
    • Oct 23, 2019: bioMerieux – Third-Quarter 2019 Business Review
    • Oct 23, 2019: Shuwen Biotech designated as an International Cooperation Base for Medical Diagnostic Technologies
    • Oct 23, 2019: Advancing early cancer detection methods
    • Oct 22, 2019: bioMerieux – Third quarter 2019 business review
    • Oct 21, 2019: StageZero Life Sciences enters European market with Oncore Pharma and BodyCheck NL: update to clarify details within the agreement
    • Oct 21, 2019: Dr. Mark H. Pollack named Chief Medical Officer for Myriad Neuroscience
    • Oct 15, 2019: Exact Sciences to study Cologuard in real-world setting
    • Oct 15, 2019: 2cureX continues its IP expansion by securing a patent on Its IndiTreat test in Hong Kong
    • Oct 15, 2019: Eurobio Scientific: Strong earnings growth for the first half of 2019
    • Oct 14, 2019: NetScientific: Appointment to the Board
    • Oct 10, 2019: StageZero Life Sciences enters European market with Oncore Pharma and BodyCheck NL; Multi-Year Agreement Valued at US$40 million
    • Oct 09, 2019: Volition appoints Dr. Phillip Barnes to Board of Directors
    • Oct 08, 2019: 2cureX has made an agreement with one of the largest private cancer hospitals in the Nordic countries
    • Sep 30, 2019: Immunoscore to support Immuno-oncology and microbiome research with in the ONCOBIOME consortium
    • Sep 28, 2019: ctDNA from patients with colon cancer is indicative of outcome following 3 versus 6 months of Oxaliplatin-based adjuvant treatment
    • Sep 28, 2019: Liquid Biopsy has prognostic role in colorectal cancer and potential for guiding therapy
    • Sep 27, 2019: Cellmid receives $840k R&D Tax Credit
    • Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members
    • Sep 24, 2019: Invitrocue clinical validation studies underway in Germany
    • Sep 24, 2019: Theradiag announces improved results for H1 2019
    • Sep 23, 2019: Five Idylla Performance Studies to be Presented at `European Society for Medical Oncology' congress
    • Sep 23, 2019: Cologuard gains FDA approval for use in younger americans, ages 45 to 49
    • Sep 23, 2019: Illumina names Joydeep Goswami senior vice president of corporate development and strategic planning
    • Sep 19, 2019: NetScientific announces interim results for the six months ended 30 June 2019
    • Sep 18, 2019: Bridgecom exhibits at Health Care IT Innovation Summit in Los Angeles
    • Sep 17, 2019: Volition announces breakthrough in enrichment of tumor nucleosomes
    • Sep 10, 2019: Cologuard helps more people get screened in a cost-effective way
    • Sep 05, 2019: Biocartis announces H1 2019 results
    • Sep 04, 2019: FDA grants breakthrough device designation to the Prescient Metabiomics LifeKit Prevent Test for the Early Detection of Colon Polyps and Colon Cancer
    • Sep 04, 2019: bioMerieux announces First-Half 2019 Results
    • Aug 29, 2019: MDxHealth reports half year 2019 financial results and strategic update
    • Aug 28, 2019: Cellmid: FY2019 financial results show accelerating sales growth and improved operating performance
    • Aug 14, 2019: Biohit Group half year financial report 2019
    • Aug 14, 2019: StageZero Life Sciences announces Q2 2019 progress update
    • Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results
    • Aug 12, 2019: Lineage Cell Therapeutics launches new corporate brand
    • Aug 12, 2019: VolitionRx announces second quarter 2019 financial results and business update
    • Aug 08, 2019: Invitrocue commences clinical collaboration with National University Hospital Singapore
    • Aug 08, 2019: BioTime reports second quarter 2019 financial results and provides business update
    • Aug 08, 2019: NeoGenomics announces leadership transition and reiterates recently increased 2019 financial guidance
    • Aug 08, 2019: Vermillion reports second quarter 2019 financial results
    • Aug 07, 2019: Epigenomics highlights operational achievements and reports financial results for first six months 2019
    • Aug 07, 2019: Supporting biomarker validation nationally and internationally
    • Aug 06, 2019: Todos Medical appoints Dr. Jorge Leon as medical advisor
    • Jul 31, 2019: PRA Health Sciences reports second quarter 2019 results and updates full year 2019 guidance
    • Jul 30, 2019: NeoGenomics reports 50% revenue growth to record $102 Million in the Second Quarter
    • Jul 29, 2019: Illumina reports financial results for second quarter of fiscal year 2019
    • Jul 29, 2019: Genomic Health reports 19% revenue growth and record profit in second quarter 2019, raises full-year guidance
    • Jul 29, 2019: Second-quarter revenue increased 94 percent to $200 million and Cologuard test volume increased 93 percent to 415,000
    • Jul 26, 2019: Exact Sciences: Resignation and appointment of Board of Directors
    • Jul 25, 2019: Freenome raises $160m to advance cancer diagnostic test
    • Jul 23, 2019: Eurobio Scientific's activity for the first half of 2019: Strong growth of sales
    • Jul 18, 2019: Theradiag announces first-half revenue up 9%
    • Jul 16, 2019: Illumina expands genomics accelerator to Cambridge, UK
    • Jul 12, 2019: Todos Medical to appoint Dr. Paula Trzepacz as chief medical officer and files new patent application
    • Jul 11, 2019: Illumina reports preliminary revenue for second quarter of fiscal year 2019
    • Jul 10, 2019: VolitionRx awarded an additional $1.4million in non-dilutive funding
    • Jul 09, 2019: NeoGenomics to build state-of-the-art oncology laboratory and global headquarters in Fort Myers, Florida
    • Jul 04, 2019: Researchers use artificial intelligence to establish molecular tumor classification and prognosis in patients with colorectal cancer
    • Jul 04, 2019: Cellmid sets another sales record in Q4 FY2019
    • Jul 02, 2019: GNS Healthcare chosen to present discovery of new clinical predictors of overall survival in metastatic colorectal cancer at ESMO 2019
    • Jun 27, 2019: NeoGenomics announces new $250 Million credit agreement
    • Jun 26, 2019: Rhythm signs Alfred Hospital for ColoSTAT clinical trial
    • Jun 26, 2019: Exact Sciences advances fight against colorectal cancer with opening Of new laboratory
    • Jun 19, 2019: Cancer research innovator Dr. Donald Berry joins OTraces' scientific advisory board to advance early cancer detection
    • Jun 11, 2019: New volume of Handbooks of Cancer Prevention (IARC) on screening for Colorectal Cancer with IDIBELL-ICO participation
    • Jun 06, 2019: OGT celebrates opening of new Cambridge site
    • Jun 03, 2019: Immunoscore demonstrates clinical utility in stage III colon cancer
    • Jun 03, 2019: Researcher receives grant to study cancer screenings for low-income people
    • May 31, 2019: Research from Invitae demonstrates the importance of germline multigene panel testing in guiding therapy for expanding groups of Cancer patients
    • May 29, 2019: Pacific Edge reports continued growth in FY19
    • May 29, 2019: New research refines the treatment of patients with advanced hematologic, lung, and other cancers
    • May 28, 2019: Cellmid appoints Lyramid CEO to accelerate partnering
    • May 27, 2019: Sysmex and Osaka University sign comprehensive collaboration agreement to foster innovation in the healthcare field
    • May 22, 2019: NetScientific full year results for the year ended 31 December 2018
    • May 17, 2019: Exact Sciences presents new data reinforcing performance of Cologuard
    • May 16, 2019: Biocartis Group: Idylla MSI performance study selected for publication at ASCO Conference
    • May 16, 2019: GeneNews Announces Q1 2019 Results and Provides Progress Update
    • May 15, 2019: Vermillion Reports First Quarter 2019 Financial Results
    • May 15, 2019: Guardant Health to present Precision Oncology data across the continuum of care at the ASCO Annual Meeting
    • May 09, 2019: BioTime reports first quarter 2019 financial results and provides business update
    • May 08, 2019: VolitionRx announces first quarter 2019 financial results and business update
    • May 08, 2019: Epigenomics announces 2019 first quarter financial results
    • May 07, 2019: Myriad Genetics reports fiscal third-quarter 2019 financial results
    • May 07, 2019: Genomic Health announces first quarter 2019 financial results
    • May 02, 2019: Important biomarker may help predict if immunotherapy is the right choice for metastatic colorectal cancer patients
    • May 01, 2019: PRA Health Sciences reports first quarter 2019 results
    • Apr 30, 2019: First-quarter revenue and cologuard test volume increased 79 percent to $162 million and 334,000, respectively
    • Apr 30, 2019: Metabolomic Technologies receives US patent covering methods of assessment of Colorectal Cancer and Colorectal Polyps by measurement of metabolites in urine
    • Apr 30, 2019: NeoGenomics announces 51% Revenue Growth to Record $96 Million in the First Quarter
    • Apr 25, 2019: Biocartis Group Q1 2019 Business Update
    • Apr 25, 2019: NetScientific announces resignation of CEO
    • Apr 25, 2019: Illumina reports financial results for first quarter of fiscal year 2019
    • Apr 24, 2019: MDxHealth provides Q1 2019 business update
    • Apr 24, 2019: U of T Researchers receive 1.5 million to improve cancer screening among
    • Apr 24, 2019: bioMerieux: First-quarter 2019 business review
    • Apr 23, 2019: Illumina accelerator invests in four startups for ninth cycle
    • Apr 18, 2019: Pacific Edge appoints John Duncan to the Board as an Independent Director
    • Apr 08, 2019: Blood-based screen for colon cancer shows promise
    • Apr 04, 2019: Theradiag and HOB Biotech settle their legal dispute
    • Apr 04, 2019: Independence supports efforts to increase colorectal cancer screening rates in Philadelphia, which are among the nation's lowest
    • Apr 03, 2019: GeneNews announces Q4 2018 results and provides progress update
    • Mar 28, 2019: Starting colorectal cancer screening at 45 would avert deaths, but testing older adults would do more
    • Mar 27, 2019: Theradiag reports its 2018 full-year results
    • Mar 27, 2019: Epigenomics reports results for financial year 2018
    • Mar 27, 2019: Colorectal Cancer Alliance to Receive $500,000 from Independence Blue Cross for March Forth Philadelphia Prevention Project
    • Mar 26, 2019: Immunoscore CR for Immunotherapies at AACR 2019
    • Mar 21, 2019: There is more than one way to get screened for colorectal cancer
    • Mar 20, 2019: LAM to present data for cell-free DNA methylation assay for noninvasive diagnosis of liver, breast and colorectal cancers At AACR Annual Meeting 2019
    • Mar 19, 2019: Kathleen Sebelius appointed to Exact Sciences Board
    • Mar 18, 2019: NetScientific: Orderly wind up of Wanda and Vortex
    • Mar 15, 2019: U.S. Representatives Payne and Marchant introduce Bi-Partisan colorectal cancer detection bill
    • Mar 14, 2019: BioTime reports fourth quarter and full year 2018 financial results and provides business update
    • Mar 13, 2019: VolitionRx announces full fiscal year 2018 financial results and business update
    • Mar 13, 2019: Non-Invasive Screenings for Colorectal Cancer Should Encourage More Americans to Pursue Routine Testing, Advocates Say
    • Mar 12, 2019: 2cureX expands its activities to preventive cancer medicine
    • Mar 12, 2019: BioChain responds to Epigenomics' unilateral termination of license contract
    • Mar 07, 2019: Combinatorial Signature Outperforms Standard-of-care Methods in Stratifying Colorectal Cancer Patients for Prognosis
    • Mar 04, 2019: WVU researchers pursue blood test for colorectal cancer
    • Feb 28, 2019: Biocartis announces CE-IVD marking of its Idylla(TM) MSI Test
    • Feb 28, 2019: MDxHealth reports financial year 2018 results and provides outlook for 2019
    • Feb 28, 2019: Biocartis announces 2018 results and 2019 outlook
    • Feb 27, 2019: Cologuard Helps Screen Two Million People for Colorectal Cancer
    • Feb 27, 2019: PRA Health Sciences reports fourth quarter and full year 2018 results and provides first quarter and full year 2019 guidance
    • Feb 27, 2019: bioMerieux – 2018 Financial Results
    • Feb 21, 2019: 2019 Cologuard Classic Ups the Ante with New 'Hole-In-One Attendance Challenge' to drive awareness of colorectal cancer and importance of early detection
    • Feb 21, 2019: Total 2018 revenue increased 71 percent to $454 million, and 934,000 people were screened with Cologuard
    • Feb 20, 2019: Rhythm signs first study site for clinical trial for new colorectal cancer diagnostic
    • Feb 20, 2019: 2cureX reports positive results from an ongoing clinical trial in heavily pre-treated colorectal cancer patients
    • Feb 20, 2019: Biohit group financial statement release 2018
    • Feb 20, 2019: Theradiag reports annual revenues for 2018 and its year-end cash position
    • Feb 20, 2019: Renowned Pharmaceutical R&D expert Jan Lundberg joins Metabolon's board of directors
    • Feb 20, 2019: Genomic Health reports record 2018 fourth quarter and year-end financial results and provides 2019 financial guidance
    • Feb 19, 2019: MDxHealth names Michael K. McGarrity as CEO
    • Feb 19, 2019: NeoGenomics reports fourth quarter of 2018 financial results
    • Feb 13, 2019: Prevent Cancer Foundation awards $400,000 in global community grants
    • Feb 06, 2019: Illumina appoints Susan E. Siegel to its Board of Directors
    • Feb 05, 2019: Myriad Genetics reports fiscal second-quarter 2019 financial results
    • Feb 05, 2019: RDx BioScience genetic risk testing identifies harmful mutation in BRCA1 or BRCA2 human genes indicating higher likelihood of breast cancer
    • Feb 01, 2019: 2cureX gathered decision makers at new year's reception
    • Jan 29, 2019: Illumina reports financial results for fourth quarter and fiscal year 2018
    • Jan 29, 2019: Eurobio Scientific reaches the €50m sales mark in 2018
    • Jan 28, 2019: GeneNews publishes data on Colonsentry in colorectal cancer risk assessment
    • Jan 28, 2019: Cellmax life to provide blood test for Medigen Biotech's colorectal cancer cell therapy clinical trials
    • Jan 21, 2019: Metabolon names Michael Rasche as president of international business
    • Jan 18, 2019: Invitrocue roll-out of Onco-PDO services in Germany
    • Jan 17, 2019: First major step in the Immunoscore reimbursement roadmap
    • Jan 16, 2019: 2cureX strengthens the organisation via the recruitment of a CFO
    • Jan 14, 2019: MDxHealth provides business update
    • Jan 08, 2019: HalioDx establishes US facilities in Richmond, Virginia and holds a CLIA certificate of registration for Immunoscore
    • Jan 07, 2019: Biocartis announces achieving its 2018 key business objectives
    • Jan 07, 2019: Exact Sciences to report $454-455M in total revenue, 71-percent growth for 2018
    • Jan 04, 2019: BioTime announces management changes
    • Jan 02, 2019: New steps to stamp out bowel cancer
    • Dec 31, 2018: Colorectal Cancer Screening Programme Phase 2 to start tomorrow
    • Dec 31, 2018: Chief Medical Director Kari Syrjanen will retire from Biohit Oyj
    • Dec 31, 2018: Myriad Genetics announced its former CEO Peter Durkee Meldrum passed away
    • Dec 31, 2018: Chief Medical Director Kari Syrjänen will retire from Biohit
    • Dec 21, 2018: Genetic Technologies provides end of year update on the test development program
    • Dec 18, 2018: HalioDx starts building the worldwide Immunoscore distribution network
    • Dec 18, 2018: Catalyst Health Network and UnitedHealthcare's accountable care organization relationship fostering quality care at lower cost
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook